Table 5.
Clinical outcome
| Variable | Low-yield group (n = 8) | High-yield group (n = 9) | P value |
| Follow-up period (months) | 5.6 ± 2.5 | 8.9 ± 2.6 | 0.38 |
| Endocrine function | |||
| Islet graft function | 1.0 | ||
| Full function (n) | 4 | 4 | |
| Partial function (n) | 4 | 5 | |
| No function (n) | 0 | 0 | |
| SUITO index | 39.2 ± 11.0 | 40.5 ± 12.4 | 0.94 |
| Peak C-peptide (ng/mL) | 1.1 ± 0.3 | 1.6 ± 0.4 | 0.27 |
| Hemoglobin A1c (%) | 6.5 ± 0.7 | 6.8 ± 0.4 | 0.61 |
| Pain management | |||
| Regular use of narcotics at postoperative period (n) | 6 | 5 | 0.62 |
| Postoperative morphine equivalent dose (mg/day) | 115 ± 39 | 41 ± 24 | 0.12 |
SUITO indicates secretory unit of islet transplant objects.